Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rush

Showing results (241-250 of 565) with videos related to

Pageof 57
Sort By:
Depression and Anxiety|December 8, 2011
What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?Jackie K Gollan, Maurizio Fava, Benji Kurian, et al.
Journal of Sex & Marital Therapy|January 28, 2005
An open-label trial of quetiapine for antipsychotic-induced sexual dysfunctionMatthew J Byerly, Emmeline Lescouflair, Mary T Weber, et al.
Child Psychiatry and Human Development|March 13, 2021
Psychometric Evaluation of the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire in a General Youth PopulationJacqueline R Anderson, Michael Killian, Anne Fuller, et al.
Contemporary Clinical Trials|October 23, 2012
Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST)Nishank Jain, Madhukar H Trivedi, A John Rush, et al.
Nature Cell Biology|June 27, 2006
Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topologyDonald S Kirkpatrick, Nathaniel A Hathaway, John Hanna, et al.
Archives of General Psychiatry|August 2, 2002
Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placeboJames H Kocsis, Alan Schatzberg, A John Rush, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 22, 2008
Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D studyRoy H Perlis, Priya Moorjani, Jesen Fagerness, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 4, 2008
The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorderE Sherwood Brown, Michelle Murray, Thomas J Carmody, et al.
Journal of Psychiatric Practice|April 3, 2009
Predictors of attrition during one year of depression treatment: a roadmap to personalized interventionDiane Warden, A John Rush, Thomas J Carmody, et al.
Health Services Research|March 26, 2003
Catching up on health outcomes: the Texas Medication Algorithm ProjectT Michael Kashner, Thomas J Carmody, Trisha Suppes, et al.
Pageof 57

Showing results (241-250 of 565) with videos related to

Sort By:
Pageof 57
Depression and Anxiety|December 8, 2011
What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?Jackie K Gollan, Maurizio Fava, Benji Kurian, et al.
Journal of Sex & Marital Therapy|January 28, 2005
An open-label trial of quetiapine for antipsychotic-induced sexual dysfunctionMatthew J Byerly, Emmeline Lescouflair, Mary T Weber, et al.
Child Psychiatry and Human Development|March 13, 2021
Psychometric Evaluation of the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire in a General Youth PopulationJacqueline R Anderson, Michael Killian, Anne Fuller, et al.
Contemporary Clinical Trials|October 23, 2012
Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST)Nishank Jain, Madhukar H Trivedi, A John Rush, et al.
Nature Cell Biology|June 27, 2006
Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topologyDonald S Kirkpatrick, Nathaniel A Hathaway, John Hanna, et al.
Archives of General Psychiatry|August 2, 2002
Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placeboJames H Kocsis, Alan Schatzberg, A John Rush, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 22, 2008
Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D studyRoy H Perlis, Priya Moorjani, Jesen Fagerness, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 4, 2008
The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorderE Sherwood Brown, Michelle Murray, Thomas J Carmody, et al.
Journal of Psychiatric Practice|April 3, 2009
Predictors of attrition during one year of depression treatment: a roadmap to personalized interventionDiane Warden, A John Rush, Thomas J Carmody, et al.
Health Services Research|March 26, 2003
Catching up on health outcomes: the Texas Medication Algorithm ProjectT Michael Kashner, Thomas J Carmody, Trisha Suppes, et al.
Pageof 57